Over 90 Total Lots Up For Auction at One Location - WA 04/08

Qure.ai’s tech is as reliable as radiologists for COVID assessment

Press releases may be edited for formatting or style | December 01, 2020 Artificial Intelligence X-Ray
Milan,1 Dec 2020: Health tech firm Qure.ai’s diagnostic tool for COVID-19 has been used as part of a clinical study conducted in Milan by IRCCS Ospedale San Raffaele. The study focused on the early predictors of clinical outcomes of COVID-19 and showed that the performance of Qure.ai’s chest X-ray interpretation technology, qXR, was comparable to radiologists’ assessment in predicting severity in initial chest x-rays in patients with COVID-19.

Published in European Radiology, the article stated that a high qXR chest X-ray quantitative score, based on percent of lung involvement, at admission was highly predictive of mortality due to COVID-19. This was comparable to what was obtained with the RALE score, previously validated to evaluate Acute Respiratory Distress Syndrome (ARDS).

IRCCS Ospedale San Raffaele has been using qXR technology since early April to aid the efforts of their physicians in pandemic management. qXR is one of Qure.ai’s AI-driven and machine-powered healthcare tools. It automatically generates chest X-ray interpretation reports and is faster and more efficient than humans in detecting, tuberculosis, chronic obstructive pulmonary diseases, lung malignancies and medical emergencies and in evaluating COVID-19 X-rays.
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats
“As reported in our study, a qXR score ≥ 30 on chest x-rays at presentation is an independent predictor of of admission to intensive care unit (ICU) or deaths occurring before ICU admission in COVID-19 patients. These important findings of our study suggest that chest Xray and Artificial Intelligence may play a pivotal role in prognostic evaluation of COVID-19 disease” stated Professor Francesco De Cobelli, Head of Clinical and Experimental Radiology at IRCCS Ospedale San Raffaele.

Prashant Warier, CEO and co-founder of Qure.ai, said: “Our AI solution for chest X-rays qXR has proven to be useful in two areas in pandemic management. Firstly, to screen for individuals exhibiting signs of COVID-19 on a chest X-ray. Secondly, to monitor confirmed cases of COVID-19 to track the progression of the disease. Having deployed both these capabilities in hospitals and community screening programs across the globe, this study with Ospedale San Raffaele backs qXR’s ability to be an effective tool for predicting clinical outcomes at the first patient evaluation itself.”


About Qure.ai
Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.

Back to HCB News

You Must Be Logged In To Post A Comment